Cisplatin anti-tumour potentiation by tirapazamine results from a hypoxia-dependent cellular sensitization to cisplatin
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://www.nature.com/articles/6690492.pdf
Reference40 articles.
1. Adam, M., Gabalski, E. C., Oehlert, J. W., Bloch, D. A., Brown, J. M., Elsaid, A. A., Pinto, H. A. & Terris, D. J. (1999). Tissue oxygen distribution in head and neck patients. Head Neck 21: 146–153.
2. Andersson, B. S., Sadeghi, T., Siciliano, M. J., Legerski, R. & Murray, D. (1996). Nucleotide excision repair genes as determinants of cellular sensitivity to cyclophosphamide analogs. Cancer Chemother Pharmacol 38: 406–416.
3. Berezney, R. & Coffey, D. S. (1975). Nuclear protein matrix: association with newly synthesized DNA. Science 189: 291–293.
4. Brizel, D. M., Rosner, G. L., Harrelson, J., Prosnitz, L. R. & Dewhirst, M. W. (1994). Pretreatment oxygenation profiles of human soft tissue sarcomas. Int J Radiat Oncol Biol Phys 30: 635–642.
5. Brizel, D. M., Sibley, G. S., Prosnitz, L. R., Scher, R. L. & Dewhirst, M. W. (1997). Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. Int I Radiat Oncol Biol Phys 38: 285–289.
Cited by 60 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Biological Mechanisms to Reduce Radioresistance and Increase the Efficacy of Radiotherapy: State of the Art;International Journal of Molecular Sciences;2022-09-06
2. Assessing the therapeutic response of tumors to hypoxia-targeted prodrugs with an <i>in silico</i> approach;Mathematical Biosciences and Engineering;2022
3. Synthetic DNA‐Targeted Chemotherapeutic Agents And Related Tumor‐Activated Prodrugs;Burger's Medicinal Chemistry and Drug Discovery;2021-04-26
4. Schedule-dependent potentiation of chemotherapy drugs by the hypoxia-activated prodrug SN30000;Cancer Biology & Therapy;2019-05-26
5. Intravital Imaging to Monitor Therapeutic Response in Moving Hypoxic Regions Resistant to PI3K Pathway Targeting in Pancreatic Cancer;Cell Reports;2018-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3